Digital wisdom in the era of value and personalization
From the discovery of safe and effective targets to the identification of most promising drug candidates, we accelerate drug development by leveraging our state-of-the-art AI/ML powered discovery engine, coupled with our deep domain expertise in pharmacology and medicinal chemistry.Learn More
We integrate a systems biomedicine perspective with our advanced computational biomarker discovery platform to decipher disease & drive beneficial therapeutic innovations across indications. Founded on our holistic drug-disease-target understanding, we empower the cost-effective repurposing of drugs that have been shelved, failed, in-development, or even approved, towards novel indications.Learn More
Wielding advanced AI/ML and deep learning algorithms, we empower indication prioritization, patient stratification, and drug combination prediction, to personalize and maximize treatment benefits for all cancer patients. Our pharmacology modeling and simulation services further help optimize dosing, clinical trial design, and predict clinical outcomes, enabling new therapeutics to advance efficiently through clinical testing.Learn More
Excelra enables outcome-based market access strategies through solutions including pharmacoeconomic modeling to demonstrate effectiveness, and cogent value communication narratives to frame the healthcare dialogue with key stakeholders. Additionally, we mine Real-World Data (RWD) to build epidemiology and market forecast models to uncover population patterns of health and disease.Learn More
Data + Domain + Data Science
Excelra’s solutions are powered by a unique Dual Competence model that synergizes our multi-disciplinary scientific acumen with cutting-edge technology and data science spanning AI/ML, Deep Learning and NLP/Text Mining Algorithms. Furthermore, we offer stand-alone technology services to streamline life science R&D including Application Development, Advanced Visualizations, and Enterprise Workflow Integration.Learn More
Taming the life science data deluge
Excelra’s GOSTAR is the world’s largest structure-activity-relationship database that houses comprehensive intelligence on bio-active compounds in discovery, development, and market. Meticulously curated by hundreds of scientists from a plethora of public sources, GOSTAR facilitates rapid target validation, virtual screening, and lead optimization to accelerate drug development.
Explore our end-to-end customized chemistry content management and data curation solutions.Learn More
Excelra’s GOBIOM is the world’s largest repository of disease biomarkers, carefully curated from a vast array of sources in exploratory, preclinical and clinical domains. GOBIOM is an essential biomarker toolkit for drug development, aiding in target identification, safety/toxicity profiling, patient stratification, and clinical outcome prediction.
Explore our custom curation and content management services encompassing big data from pan-omics and multiscale systems biology.Learn More
Excelra’s IOClinica is an Immuno-Oncology focused clinical trial intelligence application that provides comprehensive, up-to-date, actionable insights into biomarker, combination strategies, clinical trial design, and competitive intelligence. Our proprietary Clinical Trial Outcome Database (CTOD) is an exhaustive and synoptic compilation of published clinical trial outcomes across more than 90 therapeutic areas; which enables rational trial design and Go/No-Go decisions. We also provide custom curation services across preclinical toxicity reports, clinical trial protocols and outcomes.Learn More
Regulatory grade, analysis-ready Real World Evidence (RWE) can support regulatory decisions, uncover new off-label uses, establish historical controls, and enable outcome-based reimbursement decisions. Excelra synthesizes Real-World Evidence by curating, integrating and harmonizing healthcare datasets like EMRs, claims, registries, etc. into a standard data model or customized to dovetail into client requirements.Learn More